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A B S T R A C T
Background
At birth, infants’ lungs are fluid-filled; this fluid must be replaced by air to allow for effective breathing. Some infants are judged to have
inadequate breathing at birth and are resuscitated with positive pressure ventilation (PPV). Giving prolonged (sustained) inflations at
the start of PPV may help clear lung fluid and establish gas volume in the lungs.
Objectives
To assess the efficacy of initial sustained (> one second duration) lung inflation compared to standard inflations (≤ one second) in
newly born infants receiving resuscitation with intermittent PPV.
Search methods
We searched on PubMed (1966 to 1 February 2015), EMBASE (1980 to 1 February 2015) and the Cochrane Central Register of
Controlled Trials (the Cochrane Library 2015). No language restrictions were applied. We searched the abstracts of the Pediatric
Academic Societies (PAS) from 2000 to 2014.
Selection criteria
Randomised controlled trials (RCTs) and quasi-RCTs comparing giving initial sustained lung inflations (SLI) vs. standard inflations
to infants receiving resuscitation with PPV at birth.
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Data collection and analysis
We assessed methodological quality of the included trials using Cochrane Effective Practice and Organisation of Care Group (EPOC)
criteria (assessing randomisation, blinding, loss to follow-up and handling of outcome data). We evaluated the treatment effect using a
fixed-effect model using risk ratio for categorical data and using mean, standard deviation (SD) and weighted mean difference (WMD)
for continuous data.
Main results
Two trials enrolling 352 infants met our inclusion criteria. There were no differences in the rates of mortality during hospitalisation
(RR 1.59, 95% CI 0.81 to 3.10; two trials, 352 infants), intubation in the first three days of life (RR 0.85, 95% CI 0.72 to 1.02;
two trials, 352 infants) or chronic lung disease (RR 1.06, 95% CI 0.79 to 1.42; two trials, 349 infants) between infants who received
sustained versus standard inflations. The rate of patent ductus arteriosus (reported as need for pharmacological treatment) was higher
in the sustained inflation group (RR 1.27, 95% CI 1.03 to 1.56; two trials, 352 infants).
Authors’ conclusions
At present there is insufficient evidence from clinical trials to determine the efficacy and safety of initial sustained lung inflation for
newborn infants resuscitated with PPV. RCTs comparing PPV with and without sustained inflations at neonatal resuscitation are
warranted.
P L A I N L A N G U A G E S U M M A R Y
Prolonged lung inflation for neonatal resuscitation
Review question
Does the use of sustained (> one second duration) lung inflations compared to standard inflations (≤ one second) improve survival
and other important outcomes in newly born infants receiving resuscitation at birth?
Background
At birth, human lungs are filled with fluid which must be replaced by air for infants to breathe properly. Some infants have difficulty in
establishing effective breathing at birth and one in every 20 to 30 newborns receive help to do so. A variety of devices are used to help
infants begin their normal breathing. Some of these devices allow the caregivers to give long (or sustained) inflations. These sustained
inflations may help inflate the lungs and keep the lungs inflated better than if they are not used.
Study characteristics
We searched for all randomised and quasi-randomised controlled trials that studied sustained inflation compared to standard inflations
in neonatal resuscitation up to 1 Febuary 2015. Two RCTs enrolling 352 infants met our inclusion criteria.
Results
The two included trials provided insufficient evidence to determine if the risk of death during hospitalisation, intubation in the first
three days of life, or chronic lung disease are different between infants who received sustained versus standard inflations. We assessed
the quality of evidence using the Grading of Recommendations Assessment, Development and Evaluation (GRADE) approach. Several
studies are ongoing.
B A C K G R O U N D
Description of the condition
At birth infants’ lungs are filled with fluid which must be cleared
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for effective respiration to occur. Most newly born infants achieve
this spontaneously and may use considerable negative pressures
(up to -50 cmH2O) for initial inspirations (Karlberg 1962;Milner
1977). However, it is estimated that 3% to 5% of newly born
infants receive some help to breathe at delivery (Saugstad 1998).
Adequate ventilation is the key to successful neonatal resuscitation
and stabilisation (AHA 2010). Positive pressure ventilation (PPV)
is recommended for infants who have absent or inadequate respi-
ratory efforts and or bradycardia at birth (AHA 2010). The use of
manual ventilation devices - self-inflating bags, flow-inflating (or
anaesthetic) bags and T-piece devices - with a face mask or endo-
tracheal tube (ETT) is advised. Though not described in “Interna-
tional Liaison Committee on Resuscitation” (ILCOR) guidelines,
respiratory support of infants in the delivery room using a me-
chanical ventilator and nasopharyngeal tube has been described
(Lindner 1999).
Description of the intervention
The devices recommended for PPV in the delivery room differ
in their physical characteristics and ability to deliver sustained in-
flations. The most commonly used self-inflating bag (O’Donnell
2004a; O’Donnell 2004b) is of insufficient size to sustain an infla-
tion > one second. Both flow-inflating bags and T-pieces may be
used to deliver Inflations of > one second. Although target infla-
tion pressures and long inspiratory times are achieved more con-
sistently in mechanical models when using T-piece devices than
when using bags, no recommendation is made as to which device
may be preferable (AHA 2010; ERC 2010).
How the intervention might work
Boon 1979 described a study of 20 term infants delivered by Cae-
sarean section under general anaesthesia resuscitated with a T-
piece via an ETT. The trial authors reported that gas continued to
flow through the flow sensor placed between the T-piece and ETT
toward the infant at the end of a standard one second inflation
on the respiratory traces they obtained (Boon 1979). Based on
this observation, this group performed a non-randomised trial of
giving sustained inflations with a T-piece and ETT to nine term
infants during delivery room resuscitation. They reported that an
initial five second inflation with a T-piece produced a two-fold
increase in inflation volume compared to standard resuscitation
techniques (Vyas 1981). Citing these studies, a retrospective co-
hort study described the effects of a change in management strat-
egy of extremely low birth weight infants in the delivery room
(Lindner 1999). The new management strategy included the in-
troduction of an initial sustained inflation of 15 seconds with a
mechanical ventilator via a nasopharyngeal tube. This change in
strategy resulted in a reduction in the proportion of infants intu-
bated for ongoing respiratory support without apparent increases
in adverse outcomes. Interestingly, pulmonary morbidity in very
low birth weight infants was reported to be related directly to mor-
tality in 50% of the cases of deaths (Drew 1982). Moreover, mul-
tiple sustained inflations in very preterm infants improved both
heart rate and cerebral tissue oxygen saturation, in absence of any
detrimental effects (Fuchs 2011).
Why it is important to do this review
In the last few years the use of a sustained inflation at birth has been
differently adopted by international recommendations. While Eu-
ropeanResuscitationCouncil (ERC) guidelines suggest for the first
few inflations to maintain the initial inflation pressure for two to
three seconds (ERC 2010), the American Heart Association states
that “there is insufficient evidence to recommend an optimum
inflation time” (AHA 2010). A narrative review reported that it
may reduce the need of mechanical ventilation in preterm infants
at risk for respiratory distress syndrome (RDS) (Lista 2010). The
same author showed that sustained inflation (25 cmH2O for 15
seconds) improved respiratory outcomes compared to a historical
group (Lista 2011).
O B J E C T I V E S
To assess the efficacy of giving initial sustained (> one second du-
ration) inflations compared to standard inflations (≤ one second)
in newborn infants receiving resuscitation with intermittent PPV.
M E T H O D S
Criteria for considering studies for this review
Types of studies
Randomised controlled trials (RCTs) and quasi-RCTs. We ex-
cluded observational studies (case-control studies, case series) and
cluster-RCTs.
Types of participants
Term and preterm infants resuscitated using PPV at birth.
Types of interventions
Resuscitationwith initial sustained (> one second) inflations versus
resuscitation with regular (≤ one second) inflations.
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Types of outcome measures
Primary outcomes
• Death in the delivery room.
• Death during hospitalisation.
• Death to latest follow-up.
Secondary outcomes
• Apgar scores at one and five minutes.
• Heart rate at five minutes.
• Endotracheal intubation in the delivery room.
• Endotracheal intubation outside the delivery room during
hospitalisation.
• Surfactant administration in the delivery room or during
hospital admission.
• Need for mechanical ventilation.
• Duration in hours of respiratory support, i.e. nasal
continuous airway pressure and ventilation via an ETT
considered separately and in total.
• Duration in days of supplemental oxygen requirement.
• Chronic lung disease: the need for supplemental oxygen at
28 days of life; the need for supplemental oxygen at 36 weeks
gestational age for infants born at or before 32 weeks gestation.
• Air leaks (pneumothorax, pneumomediastinum,
pneumopericardium, pulmonary interstitial emphysema)
reported either individually or as a composite outcome.
• Cranial ultrasound abnormalities: any intraventricular
haemorrhage (IVH), grade 3 or 4 (IVH) according to Papile
classification (Papile 1978) and cystic periventricular
leukomalacia.
• Seizures including clinical and electroencephalographic.
• Hypoxic ischaemic encephalopathy for term and late
preterm infants (grade I-III - Sarnat 1976).
• Long-term neurodevelopmental outcome (rates of cerebral
palsy on physician assessment, developmental delay, i.e.
Intelligence Quotient (IQ) two standard deviations (SDs) <
mean on validated assessment tools e.g. Bayley’s Mental
Developmental Index).
• Retinopathy of prematurity (ROP) (all stages and ≥ stage
3).
• Patent ductus arteriosus (PDA) (pharmacologic treatment
and surgical ligation.
Search methods for identification of studies
See: Cochrane Neonatal Review Group (CNRG) search strategy.
Electronic searches
We searched the following electronic databases:
1. Cochrane Central Register of Controlled Trials
(CENTRAL) in the Cochrane Library, 2015 Issue 2, using
textwords “Infant, Newborn” and “sustained inflation”.
2. MEDLINE (January 1996 to 1 February 2015):
sustained[All Fields] AND “inflation”[All Fields] AND Clinical
Trial[ptyp] AND “infant, newborn”[MeSH Terms].
3. EMBASE (January 1980 to 1 February 2015) using the
limits Randomized Clinical Trial and newborn and the
EMTREE terms “sustained” AND “inflat” AND “lung”/exp OR
“lung” OR “pulmonary”.
4. Abstracts of the Pediatric Academic Society (PAS) from
2000 to 2014, electronically through the PAS web site (
abstractsonline) using the following key words: “sustained
inflation” AND “clinical trial”.
5. Perinatal Society of Australia and New Zealand (PSANZ).
No language restrictions were applied.
Searching other resources
We searched for any ongoing or prospective trials in registries us-
ing the web sites of www.clinicaltrials.gov and www.controlled-
trials.com. Also we checked for relevant articles in the list of ref-
erences in articles located through electronic searches.
Data collection and analysis
Selection of studies
Three review authors (COD, PD,MB) independently screened all
titles and abstracts to assess which trials met the inclusion criteria.
We retrieved full text copies of all papers that were potentially
relevant. Any disagreement was resolved by discussion between
the review authors.
Data extraction and management
Two review authors (MB, COD) independently undertook data
abstraction using a data extraction form developed ad hoc and in-
tegratedwith amodified version of theCochrane Effective Practice
andOrganisation of Care Group (EPOC) data collection checklist
(EPOC 2015).
We extracted the following characteristics from each included trial:
• Administrative details: author(s); published or unpublished;
year of publication; year in which trial was conducted; details of
other relevant papers cited.
• Details of the trial: study design; type, duration and
completeness of follow-up; country and location of study
informed consent and ethics approval.
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• Details of participants: birth weight, gestational age and
number of participants.
• Details of intervention: type of ventilation device used, type
of interface, duration and level of pressure of the sustained
inflation.
• Details of outcomes: Death during hospitalisation or to
latest follow-up, heart rate at five minutes, duration in hours of
respiratory support, duration in days of supplemental oxygen
requirement, long-term neurodevelopmental outcomes and any
adverse events.
We resolved any disagreements by discussion between the review
authors. We described the ongoing trials identified, where avail-
able, detailing the primary author, research question(s), methods
and outcome measures together with an estimate of the reporting
date.
Where any queries arose or where additional data were required,
we contacted the trial authors.
Assessment of risk of bias in included studies
Two review authors (MB, COD) independently assessed the
methodological quality of all eligible trials using criteria described
in the EPOC module. We resolved any discrepancies in quality
ratings by discussion and involved an arbitrator where necessary.
We used the standard quality criteria recommended by EPOC to
assess themethodological limitations of trials (risk of bias) included
in EPOC reviews.
The criteria for RCTs and quasi-RCTs were:
• Random sequence generation (selection bias).
• Allocation concealment (selection bias).
• Blinding of outcome assessment (detection bias).
• Incomplete outcome data (attrition bias).
• Selective reporting (reporting bias).
Selection bias (random sequence generation and allocation
concealment)
For each included trial, we categorized the risk of selection bias as
follows:
Random sequence generation
◦ Low risk - adequate (any truly random process e.g.
random number table; computer random number generator);
◦ High risk - inadequate (any non random process e.g.
odd or even date of birth; hospital or clinic record number);
◦ Unclear risk - no or unclear information provided.
Allocation concealment
For each included trial, we categorized the risk of bias regarding
allocation concealment as:
◦ Low risk - adequate (e.g. telephone or central
randomisation; consecutively numbered sealed opaque
envelopes);
◦ High risk - inadequate (open random allocation;
unsealed or non opaque envelopes, alternation; date of birth);
◦ Unclear risk - no or unclear information provided.
Detection bias
For each included trial, we categorized the methods used to blind
outcome assessors from knowledge of which intervention a partic-
ipant received. We assessed blinding separately for different out-
comes or classes of outcomes.
Attrition bias
For each included trial and for each outcome, we described the
completeness of data including attrition and exclusions from the
analysis. We noted whether attrition and exclusions were reported,
the numbers included in the analysis at each stage (compared
with the total randomised participants), reasons for attrition or
exclusion where reported, and whethermissing data were balanced
across groups or were related to outcomes.
Reporting bias
For each included trial, we described how we investigated the
risk of selective outcome reporting bias and what we found. We
assessed the methods as:
◦ Low risk - adequate (where it is clear that all of the
trials’ pre-specified outcomes and all expected outcomes of
interest to the review have been reported);
◦ High risk - inadequate (where not all the trials’ pre-
specified outcomes have been reported; one or more reported
primary outcomes were not pre-specified; outcomes of interest
are reported incompletely and so cannot be used; trial fails to
include results of a key outcome that would have been expected
to have been reported);
◦ Unclear risk - no or unclear information provided (the
study protocol was not available).
Other bias
For each included trial, we described any important concerns we
had about other possible sources of bias (e.g. whether there was
a potential source of bias related to the specific trial design or
whether the trial was stopped early due to some data dependent
process). We assessed whether each trial was free of other problems
that could put it at risk of bias as:
◦ Low risk - no concerns of other bias raised;
◦ High risk - concerns raised about multiple looks at the
data with the results made known to the investigators, difference
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in number of patients enrolled in abstract and final publications
of the paper;
◦ Unclear - concerns raised about potential sources of
bias that could not be verified by contacting the trial authors.
We did not score blinding of the intervention because it was not
applicable.
One review author entered data into RevMan 2014 and a second
review author checked for data entry for accuracy.
Measures of treatment effect
We conducted measures of treatment effect data analysis using
RevMan 2014. Outcome measures for dichotomous data (e.g.
death, endotracheal intubation in the delivery room, frequency of
retinopathy) were determined as a risk ratio (RR) with 95% con-
fidence intervals (CIs). We calculated continuous data (e.g. dura-
tion of respiratory support, Apgar score) using themean difference
(MD) and SDs.
Dealing with missing data
In case of missing data, we contacted the trial authors to request
missing data.
Assessment of heterogeneity
As a measure of consistency we used the I² statistic and Q (Chi²
test) (Deeks 2011). Statistical significance of the Q (Chi-squared)
statistic was judged by P < 0.10 because of the low statistical power
of the test.We used the following cut-offs for heterogeneity: < 25%
no (none) heterogeneity; 25 to 49% low heterogeneity; 50 to 74%
moderate heterogeneity; and ≥ 75% high heterogeneity (Higgins
2003). We combined the trials using the fixed-effect model, re-
gardless of statistical evidence for heterogeneity effect sizes.
Data synthesis
We performed statistical analyses using RevMan 2014. We used
the standard methods of the Cochrane Neonatal Review Group.
For categorical data we used relative risk (RR), relative risk reduc-
tion, and absolute risk difference (RD). Mean and SD were ob-
tained for continuous data and analysis performed using MD and
weighted mean difference (WMD) when appropriate. We calcu-
lated 95% CIs. We presented the number needed to treat for an
additional beneficial outcome (NNTB) and the number needed to
treat for an additional harmful outcome (NNTH), as appropriate.
For each comparison reviewed, meta-analysis could be feasible if
more than one eligible trial was identified and there was sufficient
homogeneity among the trials with respect to participants and in-
terventions. We combined the trials using the fixed-effect model,
regardless of statistical evidence for heterogeneity effect sizes. For
estimates of RR and RD, we used the Mantel-Haenszel method.
Subgroup analysis and investigation of heterogeneity
We planned to perform the following subgroup analyses of the
safety and efficacy of sustained inflations during resuscitation in
subgroups:
• Of term (≥ 37 weeks gestation) and preterm (< 37 weeks)
infants.
• Determined by the type of ventilation device used (self-
inflating bag, flow-inflating bag, T-piece, mechanical ventilator).
• Determined by the interface (i.e. face mask, ETT,
nasopharyngeal tube) used.
• Determined by the duration of the sustained inflation (i.e.
> one second to five seconds, > five seconds).
R E S U L T S
Description of studies
See the Characteristics of included studies; Characteristics of
excluded studies; Characteristics of ongoing studies; Characteris-
tics of studies awaiting classification sections for details.
Included studies
Two trials recruiting 352 infants met the inclusion criteria
(Lindner 2005; Lista 2015). We have listed the details of these
trials in the Characteristics of included studies section.
Lindner 2005 was a single centre RCT considering newborns re-
quiring resuscitation in the delivery room.
The median birth weight (range) was 870 (410 to 1320) g in
the sustained inflations group and 830 (370 to 1370) g in the
conventional (standard) group.Themedian gestational age (range)
was 27.0 (25.0 to 28.9) weeks in the sustained inflations group
and 26.7 (25.0 to 28.9) weeks in the conventional group.
Infants received support from a mechanical ventilator via a na-
sopharyngeal tube, fixed at 4 cm to 5 cm.Themouth and the other
nostril were closed by hand. Infants were randomised to receive
either sustained inflation or nasal intermittent mandatory venti-
lation (NIMV), before starting nasal continuous positive airways
pressure (NCPAP). Sustained inflation consisted of a 15 second
inflation with peak inflation pressure (PIP) 20 cmH2O , whereas
NIMV was performed with the following parameters: PIP 20
cmH2O, positive end expiratory pressure (PEEP) 4 to 6 cmH2O;
inflation time 0.5 seconds; inflation rate 60 per minute). The in-
fants were then supported with NCPAP at 4 to 6 cmH2O. Infants
in both groups who had apnoea on NCPAP could be treated with
NIMV (PIP 20 cmH2O; inflation time 0.3 seconds; inflation rate
60 per minute) for up to four minutes. Infants who did not re-
spond satisfactorily in the sustained inflation group received up
to two further 15 second inflations at higher inflating pressures
6Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(25 and 30 cmH2O). Infants whose response remained unsatisfac-
tory were intubated and mechanically ventilated. Treatment was
deemed to have failed if infants had persistently poor respiratory
effort, bradycardia or cyanosis/low SpO2 in the delivery room;
or if criteria combining clinical assessments of respiratory distress
and evidence of impaired oxygenation, impaired ventilation (high
CO2) or apnoea were met within 48 hours of birth.
Lista 2015 conducted a multicentre RCT of sustained lung in-
flation (SLI). Infants were included if they were born at 25 + 0
weeks to 28 + 6 weeks gestation and at high risk of RDS. Infants
were excluded if they had fetal hydrops, major congenital malfor-
mation or inherited metabolic diseases. Infants were stratified by
centre and to gestational age (GA). The sustained inflations group
(N = 148) received PIP of 25 cmH2O delivered for 15 seconds
and then reduced to a PEEP of 5 cmH2O. The control group (N
= 143) was resuscitated at birth according to American Academy
of Pediatrics (AAP) guidelines without SLI manoeuvre. SLI and
NCPAP were delivered by using a neonatal mask and a T-piece
ventilator.
The primary endpoint was need of MV in the first 72 hrs of life.
Secondary endpoints were need and duration of any respiratory
support and survival without bronchopulmonary dysplasia (BPD)
at 36 weeks post GA. Significantly fewer infants were ventilated in
the first 72 hours of life in the SLI group (79 of 148 (53%)) than
in the control group (93 of 143 (65%)); unadjusted odds ratio:
0.62 (95% CI 0.38 to 0.99; P = 0.04). The need for respiratory
support and survival without BPD did not differ between the
groups. Pneumothorax occurred in 1% (n = 2) of infants in the
control group compared with 6% (n = 9) in the SLI group, with an
unadjusted odds ratio of 4.57 (95% CI 0.97 to 21.50; P = 0.06).
Excluded studies
We have summarized the reasons for excluding potentially el-
igible trials (Bouziri 2011; Harling 2005; te Pas 2007) in the
Characteristics of excluded studies table.
In particular, we excluded te Pas 2007 because sustained inflation
was only one element of the intervention and it is not possible to
determine the relative contribution of the various elements of this
intervention to the differences observed between the groups. We
excluded Harling 2005 as infants in this trial were randomised to
receive a two second or five second inflation at the initiation of
PPV. All infants thus received sustained (> one second) inflations
as defined in our protocol (O’Donnell 2004).
Risk of bias in included studies
We have presented a summary of the ’Risk of bias’ assessment in
Figure 1 and Figure 2 Also, we have given details of the method-
ological quality of the included trials in the Characteristics of
included studies section.
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Figure 1. Risk of bias summary: review authors’ judgements about each risk of bias item for each included
trial.
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Figure 2. Risk of bias graph: review authors’ judgements about each risk of bias item presented as
percentages across all included trials.
In both included trials (Lindner 2005; Lista 2015) the risk of se-
lection bias was low (block randomisation was performed; strati-
fication for gestational age and the method of allocation conceal-
ment were reported in detail (opaque, numbered envelopes)). Al-
though the intervention was unblinded in both trials (leading to
high potential for risk of bias), in Lista 2015 researchers assessing
trial endpoints were blinded to the nature of the study treatments.
Lindner 2005 was stopped after the interim analysis and presented
unclear information about this decision.
We were unable to explore possible bias through funnel plots be-
cause only two trials met the inclusion criteria of this Cochrane
review.
Effects of interventions
Comparison: Use of initial sustained inflations vs.
standard inflations in newborns receiving
resuscitation
Primary outcomes
Death in the delivery room
One trial (N = 61) reported on this outcome, with no events
(Lindner 2005). We obtained data for this outcome directly from
the trial authors.
Death during hospitalisation
Both trials (N = 352) reported on this outcome (RR 1.59, 95%CI
0.81 to 3.10; I2 statistic = 11%; Analysis 1.1). In Lindner 2005,
the three deaths occurred in the sustained inflation group: at day 1
(respiratory failure), at day 36 (necrotizing enterocolitis) and day
107 (liver fibrosis of unknown origin). In Lista 2015 12 infants
in the control group and 17 in the sustained inflations group died
during the trial.
Secondary outcomes
Apgar score at one minute
One trial (N = 61) reported on this outcome (MD 0.40, 95% CI
-0.55 to 1.35; test for heterogeneity was not applicable; Analysis
1.2). We obtained data for this outcome directly from the trial
authors (Lindner 2005).
Apgar score at five minutes
One trial (N = 61) reported on this outcome (MD 0.00, 95% CI
-1.00 to 1.00; the test for heterogeneity not applicable because
only Lindner 2005 reported on this outcome; Analysis 1.3).
Endotracheal intubation in the delivery room
One trial (N = 61) reported on this outcome (RR 1.38, 95% CI
0.61 to 3.16; the test for heterogeneity not applicable because only
Lindner 2005 reported on this outcome; Analysis 1.4).
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Endotracheal intubation outside the delivery room during
hospitalisation
Both included trials (N = 352) reported on this outcome (RR
0.85, 95% CI 0.72 to 1.02; I2 statistic = 0; Analysis 1.4). For both
trials, data referred to 72 hours of life.
Surfactant administration in the delivery room
One trial (N = 61) reported on this outcome (RR 1.74, 95% CI
0.66 to 4.60; the test for heterogeneity not applicable because only
one trial (Lindner 2005) reported on this outcome; Analysis 1.5).
Surfactant administration during hospital admission
Both included trials (N =352) reported on this outcome (RR 0.97,
95% CI 0.85 to 1.10; I2 statistic = 0; Analysis 1.5). For Lindner
2005, we obtained data for this outcome directly from the trial
authors.
Need for mechanical ventilation
One trial (N = 291) reported on this outcome (RR 0.87, 95% CI
0.73 to 1.03; the test for heterogeneity not applicable because only
one trial (Lista 2015) reported on this outcome; Analysis 1.6).
Duration of nasal continuous airway pressure
One trial (N = 61) reported on this outcome (MD -5.40, 95% CI
-12.52 to 1.72; the test for heterogeneity not applicable; Analysis
1.7). We obtained data for this outcome directly from the trial
authors and they refer to survivors at time of assessment (Lindner
2005).
Duration of ventilation via an ETT
One trial (N = 61) reported on this outcome: MD 0.70, 95%
CI -9.23 to 10.63, the test for heterogeneity was not applicable;
Analysis 1.8). Data for this outcome refer to survivors at time of
assessment (Lindner 2005).
Duration in hours of respiratory support (nasal continuous
airway pressure and ventilation via an ETT, considered in
total)
One trial (N = 61) reported on this outcome (MD -4.80, 95% CI
-18.34 to 8.74; the test for heterogeneity not applicable; Analysis
1.9). We obtained data for this outcome were obtained directly
from the trial authors and the data refer to survivors at time of
assessment (Lindner 2005).
Chronic lung disease, i.e. the need for supplemental oxygen
at 36 weeks gestational age for infants born at or before 32
weeks gestation
Both included trials (N = 349) reported on this outcome (RR
1.06, 95% CI 0.79 to 1.42; I2 statistic = 0; Analysis 1.10). For
Lindner 2005, data for this outcome refer to survivors at time of
assessment.
Air leaks (pneumothorax, pneumomediastinum,
pneumopericardium, pulmonary interstitial emphysema)
reported either individually or as a composite outcome
Both included trials (N =352) reported on this outcome (RR 1.93,
95% CI 0.75 to 5.01; I2 statistic = 66%; Analysis 1.11).
Any intraventricular haemorrhage (IVH), grade 3 or 4 (IVH)
according to Papile classification (Papile 1978)
Both included trials (N =352) reported on this outcome (RR 1.45,
95% CI 0.67 to 3.14; I2 statistic = 0; Analysis 1.12).
Cystic periventricular leukomalacia
Both trials (N = 352) reported on this outcome (RR 0.32, 95%
CI 0.09 to 1.15; I2 statistic = 0; Analysis 1.12).
Rate of retinopathy of prematurity (ROP) ≥ stage 3
Both trials (N = 349) reported on this outcome (RR 1.11, 95%
CI 0.60 to 2.06; I2 statistic = 0; Analysis 1.13). For Lindner 2005,
data refer to survivors at time of assessment.
Rate of PDA - pharmacological treatment
Both trials (N = 352) reported on this outcome. There was a
significant difference in rate of PDA (pharmacological treatment)
favouring the standard inflation group (RR 1.27, 95% CI 1.03 to
1.56; I2 statistic = 0; Analysis 1.14).
Rate of PDA - surgical closure
One trial (N = 291) reported on this outcome (RR 0.60, 95%
CI 0.20 to 1.80; the test for heterogeneity not applicable (Lista
2015); Analysis 1.14)
The data refer to all randomised infants, unless differently speci-
fied.
No data were reported on the following outcomes: death to latest
follow-up; heart rate; duration in days of supplemental oxygen
requirement; need for supplemental oxygen at 28 days of life;
seizures including clinical and electroencephalographic; hypoxic
ischaemic encephalopathy in term and late preterm infants (grade
I-III - Sarnat 1976); or long-term neurodevelopmental outcome.
Subgroup analysis
We were unable to conduct any subgroup analysis as only we
included only two trials.
D I S C U S S I O N
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Summary of main results
We evaluated the merits of sustained lung inflation compared to
intermittent ventilation in infants requiring resuscitation and sta-
bilisation at birth. Only two trials enrolling 352 preterm infants
met the inclusion criteria (Lindner 2005; Lista 2015). Both trials
enrolled infants 25+0 to 28+6 weeks. There was insufficient evi-
dence to determine the efficacy and safety of sustained lung in-
flation compared to conventional inflations. However, the rate of
PDA (reported as need for pharmacological treatment) was in-
creased in the sustained lung inflation group. We identified three
ongoing trials.
Overall completeness and applicability of
evidence
To date, 352 newborns have been enrolled in two trials compar-
ing the use of sustained versus standard inflations for initial re-
suscitation. Other larger trials are required to confirm the current
evidence.
The three ongoing trials that we identified have important
differences in the choice of gestational age (NCT01255826;
NCT01739114;NCT02139800).NCT02139800 enrolls infants
23 to 26 weeks, NCT01255826 27 to 33 weeks, NCT01739114
< 34 weeks. This discrepancy might prove to be important, as it
has been reported that sustained inflation was more effective in
infants of 28 to 30 weeks, as compared to either infants < 28 or >
30 weeks gestation (te Pas 2007).
There were insufficient data available to assess clinically important
outcomes which were identified a priori. Outcomes such as death
in the delivery room, heart rate, duration of supplemental oxygen
requirement, and long-term neurodevelopmental outcome were
not reported. Term infants were excluded. We could not perform
a priori subgroup analysis (gestational age, ventilation device, in-
terface, duration of the sustained inflation) to detect differential
effects as there were only two included RCTs.
Quality of the evidence
We included only two trials in this Cochrane review. Lindner
2005 was stopped before target sample was recruited due to slow
enrolment. The overall quality of the evidence was judged to be
“low” due to the presence of detection and attrition bias. Themore
recent and larger trial, Lista 2015, was not affected by any relevant
bias.
Potential biases in the review process
A major limitation to this Cochrane review was the definition of
the sustained inflation as the trials used different duration and
different pressure, which may have impacted on the results. None
of the trials was blinded due to the nature of the intervention.
We excluded a potentially relevant trial, te Pas 2007, because sus-
tained inflation was only one element of the intervention and it is
not possible to determine the relative contribution of the various
elements of this intervention to the differences observed between
the two groups.
We excluded Harling 2005 because the control group consisted
of a two seconds inflation (five seconds for intervention), whereas
we defined sustained if > one second.
Agreements and disagreements with other
studies or reviews
One other systematic review of sustained lung inflation has been
recently published (Schmölzer 2014). Schmölzer 2014 conducted
a systematic review of randomised clinical trials comparing SLI
versus IPPV as the primary respiratory intervention during respi-
ratory support in preterm population < 33 weeks gestational age
in the delivery room. The review includes four trials, including
two trials that we excluded from our systematic review (Harling
2005; te Pas 2007). Schmölzer 2014 reported a significant re-
duction in the need for mechanical ventilation within 72 hours
after birth (typical relative risk 0.87, 95% CI 0.77 to 0.97). As
with our analysis, significantly more infants treated with SLI re-
ceived treatment for PDA (RR 1.27, 95% CI 1.05 to 1.54). There
were no differences in BPD, death at the latest follow-up, and the
combined outcome of death or BPD among survivors between
the groups. Schmölzer 2014’s findings differ from this Cochrane
review because of the different definition of the duration of the
intervention, and therefore in the determination of the included
trials.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
There is insufficient evidence to establish the effects of sustained
lung inflation for infants receiving respiratory support at birth.
The optimal inflation time and inflation pressure required to es-
tablish an effective functional residual capacity in infants requiring
resuscitation and stabilization in the delivery room remains to be
determined.
Implications for research
RCTs of sustained lung inflation for infants receiving respiratory
support at birth are warranted. These trials should aim to enrol in-
fants who are at higher risk of these outcomes (i.e. preterm infants)
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and should be stratified by gestational age. Long-term neurode-
velopmental outcomes (e.g. Bayley Scales of Infant Development
administered at two years corrected age) should be measured.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Lindner 2005
Methods RCT
Participants Newly born infants 25 to 28 weeks gestation inclusive without malformations, oligo-
anhydramnios, 20 weeks gestation or feto-fetal transfusion syndrome, with respiratory
distress. A total of 61 infants were enrolled (31 in the sustained inflation group and 30
in the control group)
Interventions Sustained inflation or NIMV before starting NCPAP. Infants received support from a
mechanical ventilator via a nasopharyngeal tube; and were randomised to receive a 15
second inflation with PIP 20 cmH2O or NIMV (PIP 20 cmH2O, PEEP 4 to 6 cmH2O;
inflation time 0.5 seconds; inflation rate 60 per minute) for 30 seconds prior to starting
NCPAP at 4 to 6 cmH2O. Infants in both groups who had apnoea on NCPAP could be
treated with NIMV (PIP 20 cmH2O; inflation time 0.3 seconds; inflation rate 60 per
minute) for up to 4 minutes. Infants who did not respond satisfactorily (persistent poor
or laboured respiratory effort, bradycardia or cyanosis and low oxygen saturation (SpO2)
) in the sustained lung inflation group received up to two further 15 second inflations
at higher inflating pressures (25 and 30 cmH2O). Infants whose response remained
unsatisfactory were intubated and mechanically ventilated. Treatment was deemed to
have failed if infants had persistently poor respiratory effort, bradycardia or cyanosis/
low SpO2 in the the delivery room; or if criteria combining clinical assessments of
respiratory distress and evidence of impaired oxygenation, impaired ventilation (high
CO2) or apnoea were met in within 48 hours of birth.
Outcomes Primary outcome: rate of infants reaching criteria for intubation and mechanical venti-
lation < 48 hours of life
Secondary outcomes: mortality, Apgar score, endotracheal intubation, surfactant admin-
istration, duration of respiratory support, chronic lung disease, air leak, intraventricular
haemorrhage, cystic periventricular leukomalacia, retinopathy of prematurity, PDA
Notes Trial was stopped before target sample was recruited due to slow enrolment. Clinical
outcomes were reported for all randomised infants
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Block randomised, stratified for gestational age (25 to 26 weeks,
27 to 28 weeks)
Allocation concealment (selection bias) Low risk Sealed opaque envelopes used.
Blinding of outcome assessment (detection
bias)
All outcomes
High risk Unblinded intervention.
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Lindner 2005 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk All infants accounted for.
Selective reporting (reporting bias) Low risk All reported outcomes provided with complete results.
Other bias High risk The trial lacks of power because only 61 infants were enrolled
(instead of 110)
Lista 2015
Methods Multicentre prospective randomised parallel controlled trial
Infants were assigned immediately after birth before the first breath to receive either SLI
maneuvers and NCPAP or NCPAP alone in a 1:1 ratio in permuted blocks of variable
size. Randomization was stratified according to centre and gestational age (25 or 26
weeks and 27 or 28 weeks). Group assignment was contained in sequentially numbered,
sealed, opaque envelopes that were prepared by an independent statistician. The trial
was not blinded
Participants Newly born infants 25 to 28 weeks gestation inclusive without major congenital malfor-
mations (i.e. congenital heart, cerebral, lung, abdominal malformations), fetal hydrops,
and lack of parental consent. A total of 294 infants were enrolled (150 in the sustained
lung inflation group and 144 in the control group)
Interventions Infants in the SLI group underwent the following approach: after oropharyngeal and
nasal suctioning, a pressure-controlled (25 cm H2O) inflation was sustained for 15
seconds, followed by the delivery of 5 cm H2O CPAP, using a neonatal mask and T-
piece ventilator. Patients were observed for the next 6 to 10 seconds to evaluate their
cardiorespiratory function. If respiratory failure persisted (i.e. apnoea, gasping) or the
heart rate was 60 and 100 beats/min despite CPAP, the SLI maneuver (again 25 cmH2O
for 15 seconds) was repeated. If the heart rate remained 60 and 100 beats/min after the
second SLI maneuver, the infant was resuscitated following the guidelines of the AAP
Infants in the control group were treated with NCPAP at 5 cmH2O and were assisted
according to the guidelines of AAP. Infants in both groups who were not intubated in the
delivery room were transferred to the NICU on NCPAP at 5 cmH2O with a fraction of
inspired oxygen (FiO2) of 0.21 to 0.40 (in agreement with local protocols).
Outcomes Primary outcome: rate of infants reaching mechanical ventilation within the first 72
hours of life
Secondary outcomes: MV in the first 3 hours of life, highest FiO2, duration of NCPAP,
need and duration of bilevel NCPAP, nasal IMV, conventional or high-frequency venti-
lation, duration of hospitalisation, need and number of doses of surfactant, occurrence
of RDS, BPD, and mortality
Notes
Risk of bias
Bias Authors’ judgement Support for judgement
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Lista 2015 (Continued)
Random sequence generation (selection
bias)
Low risk Block randomised (1:1 ratio), stratified for
gestational age (25 to 26 weeks, and 27 to
28 weeks)
Allocation concealment (selection bias) Low risk Group assignment was contained in se-
quentially numbered, sealed, opaque en-
velopes that were prepared by an indepen-
dent statistician and distributed to partici-
pating centres
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Unblinded intervention. Researchers as-
sessing study endpoints were blinded to the
nature of the study treatments
Incomplete outcome data (attrition bias)
All outcomes
Low risk Only 0.7% (control group) and 1.3% (SLI
group) patients lost
Selective reporting (reporting bias) Low risk All outcomes reported for.
Other bias Low risk Appears free of other bias.
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Bouziri 2011 Not a clinical trial. Does not investigate sustained lung inflation
Harling 2005 The control group consisted of a two seconds inflation (five seconds for intervention): as we defined sustained if > 1
second, this trial could not be included
Infants in the SLI group were born more preterm and had lower median birth weight than in conventional group,
though the P value was not indicated. The median birth weight (range) was 885 (518 to 1460) g in the SLI group
and 1095 (560 to 1562) g in the conventional group. The median gestational age (range) was 27 (23 to 30) weeks
in the SLI group and 28 (23 to 31) weeks in the conventional group
te Pas 2007 This RCT enrolled newly born infants born at < 33 weeks gestation free of known major congenital anomalies with
respiratory distress. Infants were randomised to a 10 second inflation at 20 cmH2O with a T-piece via a nasal tube or
to intermittent PPV with a self-inflating bag via a face mask. Infants randomised to the T-piece received a 10 second
inflation at 20 cmH2O followed by NCPAP at 5 to 6 cmH2O. If the infant’s clinical response was unsatisfactory, a
further 10 second inflation at 25 cmH2O and NIMV (PIP 20 to 25 cmH2O, inflation rate 60 per minute) could be
given. If the infants’ condition improved (satisfactory heart rate and colour) but they had irregular breathing, they
could receive NIMV for several minutes. Infants who were judged to have inadequate breathing, remain bradycardic
or remain cyanosed in the delivery room after these interventions were intubated and mechanically ventilated. Infants
randomised to the self-inflating bag received initial inflations of 30 to 40 cmH2O, followed by inflations not > 20
cmH2O (the inflation time was not specified or recorded) for 30 seconds. Infants whowere judged to have inadequate
breathing, remain bradycardic or remain cyanosed in the delivery room after this intervention were intubated and
16Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes (Review)
Copyright © 2015 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
(Continued)
mechanically ventilated. Infants in the sustained lung inflation group who were not intubated were transferred to
the neonatal intensive care unit (NICU) on NCPAP at 5 to 6 cmH2O; non-intubated infants in the control group
were transferred to the NICU with supplemental oxygen and monitored with pulse oximetry
The intervention in this trial was multifaceted. In addition to a sustained inflation, many other aspects of the
respiratory care at birth differed between the groups (the ventilation device used; the interface used; whether PEEP
was used; whether NIMV was used; the time allowed for stabilisation before intubation was considered; the time of
starting NCPAP). It is not possible to determine the relative contribution (if any) of each element of this intervention
to the differences in outcomes observed between the groups
Characteristics of ongoing studies [ordered by study ID]
NCT01255826
Trial name or title Ventilatory Management of the Preterm Neonate in the Delivery Room
Methods Multicenter prospective randomised parallel controlled trial. Masking: open label
Participants Inclusion Criteria: Gestational age < 34 weeks.
Exclusion Criteria: Neonates with major congenital anomalies; Meconium aspiration syndrome, congenital
diaphragmatic hernia and anterior abdominal wall defect; Maternal chorioamnionitis; Neonates with gesta-
tional age < 26 weeks or birth weight less than 750 grams
Interventions SLI group: Pressure-controlled (20 cmH2O) inflation sustained for 15 seconds, using a neonatal mask and a
T-piece ventilator. This pressure controlled inflation will be followed by CPAP at 5 cmH2O. This procedure
will be repeated a second time with a pressure of 25 cmH2O for 15 seconds if breathing remained insufficient
and/or the heart rate is < 100 bpm and/or the infant is cyanotic. To be followed by CPAP at 6 cmH2O. A
third puff with a pressure of 30 cmH2O for 15 seconds will be used after few seconds if inadequate heart rate
and respiration was not reached. This will be followed by CPAP at 7 cmH2O
Control group: intermittent mask and bag ventilation, rate 40-60 per minute using a self-inflating bag and
mask with an oxygen reservoir
Outcomes Primary outcomes: Need of endotracheal intubation after failure of positive pressure ventilation through face
mask in the delivery room (time frame: 2 minutes); Need for MV for neonates on NCPAP (time frame: 28
days)
Secondary outcomes: Occurrence and duration of oxygen therapy; BPD; pulmonary air leak; PDA; NEC;
IVH; Neonatal sepsis; Length of NICU stay; Delivery room death or death during admission; Inflammatory
mediators before and after resuscitation
Starting date January 2011.
Contact information Dina Mohamed Shinkar, MSc, 0020121524107, drdodi@hotmail.com
Gynecology and Obstetrics hospital, Ain-Shams University, Cairo, Egypt
Notes
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NCT01739114
Trial name or title Assessment of Lung Aeration at Birth.
Methods Multicenter prospective randomised parallel controlled trial. Masking: Single Blind (Outcomes Assessor)
Participants InclusionCriteria: Infants < 33weeks gestationwho require respiratory support for resuscitation in the delivery
room
Exclusion Criteria: congenital abnormality or condition that might have an adverse effect on breathing or
ventilation; absence of parents’ consent to the study
Interventions SLI group: Two initial sustained inflations with a PIP of 20 cmH2O, followed by a PEEP of 5 cmH2O and
then CPAP if breathing spontaneously or, if found to have apnoea or laboured breathing, mask IPPV with a
PIP of 20 cmH2O and PEEP of 5 cmH2O at a rate of 40 to 60 bpm, at which time CPAP will be provided
Control group: Mask IPPV with an initial PIP of 20 cmH2O and PEEP of 5 cmH2O, and a ventilation rate
of 40 to 60 inflations/min until spontaneously breathing, at which time CPAP will be provided
Outcomes Primary outcome: BPD
Secondary outcomes: Occurrence and duration of oxygen therapy; BPD; pulmonary air leak; PDA; NEC;
IVH; Neonatal sepsis; Length of NICU stay; Delivery room death or death during admission; Inflammatory
mediators before and after resuscitation. Need of endotracheal intubation after failure of positive pressure
ventilation through face mask in the delivery room (time frame: 2 minutes); Need for MV for neonates on
NCPAP (time frame: 28 days)
Starting date August 2013.
Contact information Georg Schmolzer, MD,PhD, +1780 735 ext 5179, georg.schmoelzer@me.com
University of Alberta.
Notes
NCT02139800
Trial name or title Sustained Aeration of Infant Lungs Trial (SAIL).
Methods Two-arm randomized, controlled, multi-center clinical trial.
Participants Infants of 23-26 weeks gestational age requiring respiratory support at birth. Sample size: 600 infants
Inclusion Criteria: Gestational age at least 23 weeks but less than 27 completed weeks by best obstetrical
estimate; Requiring resuscitation/respiratory intervention at birth
Exclusion Criteria: Considered non-viable by the attending neonatologist; Refusal of antenatal informed
consent; Knownmajor anomalies, pulmonary hypoplasia;Mothers who are unable to consent for theirmedical
care and who do not have a surrogate guardian will not be approached for consent
Interventions SLI group: sustained inflation in the delivery room. The first sustained inflation will use inflation pressure of
20 cmH2O for 15 seconds
Control group: CPAP of 5-7 cmH2O in the delivery room.
Outcomes Primary outcome: combined endpoint of death or BPD at 36 weeks gestational age
Secondary outcomes: Oxygen profile over first 24 hours; Oxygen profile with highest Fraction of Inspired
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NCT02139800 (Continued)
Oxygen (FiO2) level up to 48 hours; Highest FiO2 level recorded during the first 48 hours; Heart rate in
the Delivery Room (DR); Detailed status on departure from DR; Type of respiratory support (CPAP, PPV)
and FiO2 on departure from DR; Use of inotropes on arrival in NICU; Circulatory support; Need for
intubation in DR or by 24 hours of age; Pressure-volume characteristics in DR; Chest x-ray reports showing
pneumothorax or new chest drains in the first 48 hours of life; Duration of any chest drain in-situ; Head
ultrasound and/or MRI findings of intraventricular hemorrhage; Chest x-ray between days 7-10; Death or
need for positive pressure ventilation at 7 days; Highest FiO2 and Area under the FiO2 curve for the first
week of life; Pneumothorax and pulmonary interstitial emphysema (PIE); Survival to discharge home without
BPD, retinopathy of prematurity (grades 3 & 4), or significant brain abnormalities on head ultrasound;
Duration of respiratory support (ventilation, CPAP, supplemental oxygen); Death in hospital; Retinopathy
of prematurity (ROP) stage 3 or greater requiring treatment; Use of postnatal steroids for treatment of BPD;
Length of hospital stay; Neurodevelopmental and respiratory outcome at 22-26 months corrected gestational
age
Starting date August 2014.
Contact information Haresh Kirpalani, BM, MSc, kirpalanih@email.chop.edu
Sarah J Ratcliffe, PhD, sratclif@upenn.edu.
Notes
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D A T A A N D A N A L Y S E S
Comparison 1. Use of initial sustained inflations vs. standard inflations in newborns receiving resuscitation
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Death 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
1.1 Death in the delivery
room
1 61 Risk Ratio (M-H, Fixed, 95% CI) 0.0 [0.0, 0.0]
1.2 Death before discharge 2 352 Risk Ratio (M-H, Fixed, 95% CI) 1.59 [0.81, 3.10]
2 Apgar at 1 min 1 61 Mean Difference (IV, Fixed, 95% CI) 0.40 [-0.55, 1.35]
3 Apgar at 5 mins 1 61 Mean Difference (IV, Fixed, 95% CI) 0.0 [-1.00, 1.00]
4 Endotracheal intubation 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
4.1 Endotracheal intubation
in the delivery room
1 61 Risk Ratio (M-H, Fixed, 95% CI) 1.38 [0.61, 3.16]
4.2 Endotracheal intubation
by 72 hours of age
2 352 Risk Ratio (M-H, Fixed, 95% CI) 0.85 [0.72, 1.02]
5 Surfactant administration 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
5.1 Surfactant given in the
delivery room
1 61 Risk Ratio (M-H, Fixed, 95% CI) 1.74 [0.66, 4.60]
5.2 Surfactant given at any
time
2 352 Risk Ratio (M-H, Fixed, 95% CI) 0.97 [0.85, 1.10]
6 Need for mechanical ventilation 1 Risk Ratio (M-H, Fixed, 95% CI) Totals not selected
7 Duration of NCPAP 1 58 Mean Difference (IV, Fixed, 95% CI) -5.40 [-12.52, 1.72]
8 Duration of mechanical
ventilation
1 58 Mean Difference (IV, Fixed, 95% CI) 0.70 [-9.23, 10.63]
9 Duration of respiratory support
(NCPAP + MV)
1 58 Mean Difference (IV, Fixed, 95% CI) -4.80 [-18.34, 8.74]
10 Chronic lung disease 2 349 Risk Ratio (M-H, Fixed, 95% CI) 1.06 [0.79, 1.42]
11 Pneumothorax 2 352 Risk Ratio (M-H, Fixed, 95% CI) 1.93 [0.75, 5.01]
12 Cranial ultrasound
abnormalities
2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
12.1 Intraventricular
haemorrhage grade 3-4
2 352 Risk Ratio (M-H, Fixed, 95% CI) 1.45 [0.67, 3.14]
12.2 Cystic periventricular
leukomalacia
2 352 Risk Ratio (M-H, Fixed, 95% CI) 0.32 [0.09, 1.15]
13 Retinopathy of prematurity
(ROP)
2 349 Risk Ratio (M-H, Fixed, 95% CI) 1.11 [0.60, 2.06]
14 Patent ductus arteriosus (PDA) 2 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
14.1 PDA - pharmacological
treatment
2 352 Risk Ratio (M-H, Fixed, 95% CI) 1.27 [1.03, 1.56]
14.2 PDA - surgical closure 1 291 Risk Ratio (M-H, Fixed, 95% CI) 0.60 [0.20, 1.80]
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Analysis 1.1. Comparison 1 Use of initial sustained inflations vs. standard inflations in newborns receiving
resuscitation, Outcome 1 Death.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflations vs. standard inflations in newborns receiving resuscitation
Outcome: 1 Death
Study or subgroup SLI control Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Death in the delivery room
Lindner 2005 0/31 0/30 Not estimable
Subtotal (95% CI) 31 30 Not estimable
Total events: 0 (SLI), 0 (control)
Heterogeneity: not applicable
Test for overall effect: not applicable
2 Death before discharge
Lista 2015 17/148 12/143 96.0 % 1.37 [ 0.68, 2.76 ]
Lindner 2005 3/31 0/30 4.0 % 6.78 [ 0.37, 125.95 ]
Subtotal (95% CI) 179 173 100.0 % 1.59 [ 0.81, 3.10 ]
Total events: 20 (SLI), 12 (control)
Heterogeneity: Chi2 = 1.12, df = 1 (P = 0.29); I2 =11%
Test for overall effect: Z = 1.34 (P = 0.18)
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Analysis 1.2. Comparison 1 Use of initial sustained inflations vs. standard inflations in newborns receiving
resuscitation, Outcome 2 Apgar at 1 min.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflations vs. standard inflations in newborns receiving resuscitation
Outcome: 2 Apgar at 1 min
Study or subgroup SLI control
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Lindner 2005 31 4.2 (1.9) 30 3.8 (1.9) 100.0 % 0.40 [ -0.55, 1.35 ]
Total (95% CI) 31 30 100.0 % 0.40 [ -0.55, 1.35 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.82 (P = 0.41)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
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Analysis 1.3. Comparison 1 Use of initial sustained inflations vs. standard inflations in newborns receiving
resuscitation, Outcome 3 Apgar at 5 mins.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflations vs. standard inflations in newborns receiving resuscitation
Outcome: 3 Apgar at 5 mins
Study or subgroup Sustained inflations Standard inflations
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Lindner 2005 31 8 (2) 30 8 (2) 100.0 % 0.0 [ -1.00, 1.00 ]
Total (95% CI) 31 30 100.0 % 0.0 [ -1.00, 1.00 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.0 (P = 1.0)
Test for subgroup differences: Not applicable
-10 -5 0 5 10
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Analysis 1.4. Comparison 1 Use of initial sustained inflations vs. standard inflations in newborns receiving
resuscitation, Outcome 4 Endotracheal intubation.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflations vs. standard inflations in newborns receiving resuscitation
Outcome: 4 Endotracheal intubation
Study or subgroup Sustained inflations Standard inflations Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Endotracheal intubation in the delivery room
Lindner 2005 10/31 7/30 100.0 % 1.38 [ 0.61, 3.16 ]
Subtotal (95% CI) 31 30 100.0 % 1.38 [ 0.61, 3.16 ]
Total events: 10 (Sustained inflations), 7 (Standard inflations)
Heterogeneity: not applicable
Test for overall effect: Z = 0.77 (P = 0.44)
2 Endotracheal intubation by 72 hours of age
Lindner 2005 19/31 18/30 16.2 % 1.02 [ 0.68, 1.53 ]
Lista 2015 79/148 93/143 83.8 % 0.82 [ 0.68, 1.00 ]
Subtotal (95% CI) 179 173 100.0 % 0.85 [ 0.72, 1.02 ]
Total events: 98 (Sustained inflations), 111 (Standard inflations)
Heterogeneity: Chi2 = 0.92, df = 1 (P = 0.34); I2 =0.0%
Test for overall effect: Z = 1.79 (P = 0.074)
0.05 0.2 1 5 20
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Analysis 1.5. Comparison 1 Use of initial sustained inflations vs. standard inflations in newborns receiving
resuscitation, Outcome 5 Surfactant administration.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflations vs. standard inflations in newborns receiving resuscitation
Outcome: 5 Surfactant administration
Study or subgroup Sustained inflations Standard inflations Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Surfactant given in the delivery room
Lindner 2005 9/31 5/30 100.0 % 1.74 [ 0.66, 4.60 ]
Subtotal (95% CI) 31 30 100.0 % 1.74 [ 0.66, 4.60 ]
Total events: 9 (Sustained inflations), 5 (Standard inflations)
Heterogeneity: not applicable
Test for overall effect: Z = 1.12 (P = 0.26)
2 Surfactant given at any time
Lindner 2005 18/31 17/30 13.4 % 1.02 [ 0.66, 1.58 ]
Lista 2015 109/148 110/143 86.6 % 0.96 [ 0.84, 1.09 ]
Subtotal (95% CI) 179 173 100.0 % 0.97 [ 0.85, 1.10 ]
Total events: 127 (Sustained inflations), 127 (Standard inflations)
Heterogeneity: Chi2 = 0.09, df = 1 (P = 0.76); I2 =0.0%
Test for overall effect: Z = 0.52 (P = 0.60)
Test for subgroup differences: Chi2 = 1.39, df = 1 (P = 0.24), I2 =28%
0.05 0.2 1 5 20
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Analysis 1.6. Comparison 1 Use of initial sustained inflations vs. standard inflations in newborns receiving
resuscitation, Outcome 6 Need for mechanical ventilation.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflations vs. standard inflations in newborns receiving resuscitation
Outcome: 6 Need for mechanical ventilation
Study or subgroup SLI Control Risk Ratio Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lista 2015 88/148 98/143 0.87 [ 0.73, 1.03 ]
0.01 0.1 1 10 100
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Analysis 1.7. Comparison 1 Use of initial sustained inflations vs. standard inflations in newborns receiving
resuscitation, Outcome 7 Duration of NCPAP.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflations vs. standard inflations in newborns receiving resuscitation
Outcome: 7 Duration of NCPAP
Study or subgroup Sustained inflations Standard inflations
Mean
Difference Weight
Mean
Difference
N Mean(SD)[days] N Mean(SD)[days] IV,Fixed,95% CI IV,Fixed,95% CI
Lindner 2005 28 14.5 (9.5) 30 19.9 (17.3) 100.0 % -5.40 [ -12.52, 1.72 ]
Total (95% CI) 28 30 100.0 % -5.40 [ -12.52, 1.72 ]
Heterogeneity: not applicable
Test for overall effect: Z = 1.49 (P = 0.14)
Test for subgroup differences: Not applicable
-20 -10 0 10 20
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Analysis 1.8. Comparison 1 Use of initial sustained inflations vs. standard inflations in newborns receiving
resuscitation, Outcome 8 Duration of mechanical ventilation.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflations vs. standard inflations in newborns receiving resuscitation
Outcome: 8 Duration of mechanical ventilation
Study or subgroup SLI control
Mean
Difference Weight
Mean
Difference
N Mean(SD)[days] N Mean(SD)[days] IV,Fixed,95% CI IV,Fixed,95% CI
Lindner 2005 28 15.3 (20.5) 30 14.6 (17.9) 100.0 % 0.70 [ -9.23, 10.63 ]
Total (95% CI) 28 30 100.0 % 0.70 [ -9.23, 10.63 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.14 (P = 0.89)
Test for subgroup differences: Not applicable
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Analysis 1.9. Comparison 1 Use of initial sustained inflations vs. standard inflations in newborns receiving
resuscitation, Outcome 9 Duration of respiratory support (NCPAP + MV).
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflations vs. standard inflations in newborns receiving resuscitation
Outcome: 9 Duration of respiratory support (NCPAP + MV)
Study or subgroup Sustained inflations Standard inflations
Mean
Difference Weight
Mean
Difference
N Mean(SD)[days] N Mean(SD)[days] IV,Fixed,95% CI IV,Fixed,95% CI
Lindner 2005 28 29.8 (25.7) 30 34.6 (26.9) 100.0 % -4.80 [ -18.34, 8.74 ]
Total (95% CI) 28 30 100.0 % -4.80 [ -18.34, 8.74 ]
Heterogeneity: not applicable
Test for overall effect: Z = 0.69 (P = 0.49)
Test for subgroup differences: Not applicable
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Analysis 1.10. Comparison 1 Use of initial sustained inflations vs. standard inflations in newborns receiving
resuscitation, Outcome 10 Chronic lung disease.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflations vs. standard inflations in newborns receiving resuscitation
Outcome: 10 Chronic lung disease
Study or subgroup Sustained inflations Standard inflations Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lindner 2005 4/28 6/30 10.2 % 0.71 [ 0.22, 2.27 ]
Lista 2015 57/148 50/143 89.8 % 1.10 [ 0.81, 1.49 ]
Total (95% CI) 176 173 100.0 % 1.06 [ 0.79, 1.42 ]
Total events: 61 (Sustained inflations), 56 (Standard inflations)
Heterogeneity: Chi2 = 0.51, df = 1 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 0.40 (P = 0.69)
Test for subgroup differences: Not applicable
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Analysis 1.11. Comparison 1 Use of initial sustained inflations vs. standard inflations in newborns receiving
resuscitation, Outcome 11 Pneumothorax.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflations vs. standard inflations in newborns receiving resuscitation
Outcome: 11 Pneumothorax
Study or subgroup Sustained inflations Standard inflations Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lindner 2005 3/31 4/30 66.6 % 0.73 [ 0.18, 2.97 ]
Lista 2015 9/148 2/143 33.4 % 4.35 [ 0.96, 19.78 ]
Total (95% CI) 179 173 100.0 % 1.93 [ 0.75, 5.01 ]
Total events: 12 (Sustained inflations), 6 (Standard inflations)
Heterogeneity: Chi2 = 2.95, df = 1 (P = 0.09); I2 =66%
Test for overall effect: Z = 1.36 (P = 0.17)
Test for subgroup differences: Not applicable
0.05 0.2 1 5 20
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Analysis 1.12. Comparison 1 Use of initial sustained inflations vs. standard inflations in newborns receiving
resuscitation, Outcome 12 Cranial ultrasound abnormalities.
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflations vs. standard inflations in newborns receiving resuscitation
Outcome: 12 Cranial ultrasound abnormalities
Study or subgroup Sustained inflations Standard inflations Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Intraventricular haemorrhage grade 3-4
Lindner 2005 3/31 2/30 20.0 % 1.45 [ 0.26, 8.09 ]
Lista 2015 12/148 8/143 80.0 % 1.45 [ 0.61, 3.44 ]
Subtotal (95% CI) 179 173 100.0 % 1.45 [ 0.67, 3.14 ]
Total events: 15 (Sustained inflations), 10 (Standard inflations)
Heterogeneity: Chi2 = 0.00, df = 1 (P = 1.00); I2 =0.0%
Test for overall effect: Z = 0.94 (P = 0.35)
2 Cystic periventricular leukomalacia
Lindner 2005 2/31 4/30 44.4 % 0.48 [ 0.10, 2.45 ]
Lista 2015 1/148 5/143 55.6 % 0.19 [ 0.02, 1.63 ]
Subtotal (95% CI) 179 173 100.0 % 0.32 [ 0.09, 1.15 ]
Total events: 3 (Sustained inflations), 9 (Standard inflations)
Heterogeneity: Chi2 = 0.46, df = 1 (P = 0.50); I2 =0.0%
Test for overall effect: Z = 1.74 (P = 0.082)
Test for subgroup differences: Chi2 = 3.91, df = 1 (P = 0.05), I2 =74%
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Analysis 1.13. Comparison 1 Use of initial sustained inflations vs. standard inflations in newborns receiving
resuscitation, Outcome 13 Retinopathy of prematurity (ROP).
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflations vs. standard inflations in newborns receiving resuscitation
Outcome: 13 Retinopathy of prematurity (ROP)
Study or subgroup Sustained inflations Standard inflations Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Lindner 2005 5/28 5/30 28.3 % 1.07 [ 0.35, 3.31 ]
Lista 2015 14/148 12/143 71.7 % 1.13 [ 0.54, 2.35 ]
Total (95% CI) 176 173 100.0 % 1.11 [ 0.60, 2.06 ]
Total events: 19 (Sustained inflations), 17 (Standard inflations)
Heterogeneity: Chi2 = 0.01, df = 1 (P = 0.94); I2 =0.0%
Test for overall effect: Z = 0.34 (P = 0.74)
Test for subgroup differences: Not applicable
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Analysis 1.14. Comparison 1 Use of initial sustained inflations vs. standard inflations in newborns receiving
resuscitation, Outcome 14 Patent ductus arteriosus (PDA).
Review: Sustained versus standard inflations during neonatal resuscitation to prevent mortality and improve respiratory outcomes
Comparison: 1 Use of initial sustained inflations vs. standard inflations in newborns receiving resuscitation
Outcome: 14 Patent ductus arteriosus (PDA)
Study or subgroup Sustained inflations Standard inflations Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 PDA - pharmacological treatment
Lindner 2005 13/31 7/30 9.1 % 1.80 [ 0.83, 3.88 ]
Lista 2015 88/148 70/143 90.9 % 1.21 [ 0.98, 1.50 ]
Subtotal (95% CI) 179 173 100.0 % 1.27 [ 1.03, 1.56 ]
Total events: 101 (Sustained inflations), 77 (Standard inflations)
Heterogeneity: Chi2 = 0.94, df = 1 (P = 0.33); I2 =0.0%
Test for overall effect: Z = 2.24 (P = 0.025)
2 PDA - surgical closure
Lista 2015 5/148 8/143 100.0 % 0.60 [ 0.20, 1.80 ]
Subtotal (95% CI) 148 143 100.0 % 0.60 [ 0.20, 1.80 ]
Total events: 5 (Sustained inflations), 8 (Standard inflations)
Heterogeneity: not applicable
Test for overall effect: Z = 0.90 (P = 0.37)
Test for subgroup differences: Chi2 = 1.70, df = 1 (P = 0.19), I2 =41%
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H I S T O R Y
Protocol first published: Issue 4, 2004
Review first published: Issue 7, 2015
Date Event Description
10 July 2008 Amended Converted to new review format.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
We added clinically relevant outcomes (surfactant administration, need for mechanical ventilation, retinopathy of prematurity, and
PDA).
We planned subgroup analyses according to gestational age (< 37 weeks, ≥ 37 weeks), ventilation device used (self-inflating bag, flow-
inflating bag, T-piece, mechanical ventilator), patient interface used (face mask, ETT, nasopharyngeal tube) and duration of sustained
inflation (> one second to five seconds, > five seconds). We were unable to conduct any subgroup analyses as only two trials met the
inclusion criteria.
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